Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous versus cyclic combined hormonal contraception dosing study
2006-003636-30Phase 4Active
- Sponsor
- Karolinska University Hospital
- Start
- Jan 2008
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of drospirenone, ethinyl estradiol, etonogestrel and avatrombopag in contraception (2 arms), sponsored by Karolinska University Hospital. Primary endpoint: Cardiovascular risk factors. Started Jan 2008; status: active.
02
Drugs
drospirenoneethinyl estradioletonogestrelavatrombopag
03
Conditions
contraception
Beyond the preview
Go deeper on 2006-003636-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003636-30.